Molecular Medicine Reports · 2017 · 25 citations · 20 references
Life SciencesCell BiologyOncologyApoptosisCell SignalingMolecular OncologyApoptosis In CancerCancer Cell SignalingCancer GlycobiologyGlycan SignalingOncogenic Signaling PathwaysSignal Transduction In CancerCell Viability AssaysForkhead Box O SignalingForkhead Box ProteinsFoxo Transcriptional RegulationO-glcnac SignalingO-glcnacylation In CancerPhosphoinositide PhosphorylationProtein Expression Levels
Lung cancer is the most common cause of cancer‑associated mortality worldwide, and glucosamine has the potential to exhibit antitumor activity. To reveal its anti‑lung cancer mechanism, the present study investigated the effect of glucosamine on the transcriptional activity of forkhead box O (FOXO)1 and FOXO3, and associated signal transduction pathways in A549 cells. An MTT assay was performed to investigate cell viability and immunoblotting was performed to detect protein levels of FOXO1/3, phosphorylated (p)‑FOXO1/3, AKT, p‑AKT, extracellular signal‑regulated kinase (ERK) and p‑ERK, and the levels of β‑O‑linked N‑acetylglucosamine (O‑GlcNAc)‑modified FOXO1 protein. Immunoprecipitation was performed to purify O‑GlcNAc‑modified protein prior to immunoblotting. Glucosamine inhibited FOXO1‑ and FOXO3‑specific amino acid phosphorylation, which was correlated with its translocation from the nucleus to cytoplasm, indicating a possible anti‑lung cancer mechanism of glucosamine. The present study also examined the phosphoinositide 3‑kinase (PI3K)/AKT and mitogen‑activated protein kinase (MAPK)/ERK pathways, which induce FOXO1‑ and FOXO3‑specific site phosphorylation. The data showed that glucosamine suppressed the translocation of FOXO from the cytoplasm to the nucleus via glucosamine‑induced O‑GlcNAc modification. These observations suggested that glucosamine modulated A549 cell proliferation, possibly via O‑GlcNAc modification‑induced downregulation of the PI3K/AKT and MAPK/ERK pathways and their downstream signaling molecules, FOXO1 and FOXO3.
20
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Mickey C.‐T. Hu, Dung‐Fang Lee, Weiya Xia et al. · Cell · 2004 · 866 citations · Full text
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang, Cong S. Zong, Weiya Xia et al. · Nature Cell Biology · 2008 · 699 citations